Compare CNSP & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNSP | VS |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.9M |
| IPO Year | 2019 | 2017 |
| Metric | CNSP | VS |
|---|---|---|
| Price | $3.64 | $0.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 16.2K | 12.4K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.03 | ★ 75.97 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,183,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3711.30 |
| 52 Week Low | $1.90 | $0.71 |
| 52 Week High | $10.54 | $1.86 |
| Indicator | CNSP | VS |
|---|---|---|
| Relative Strength Index (RSI) | 32.27 | 31.90 |
| Support Level | $2.01 | N/A |
| Resistance Level | $5.75 | $1.18 |
| Average True Range (ATR) | 0.53 | 0.08 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 1.09 | 13.88 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.